BioCentury
ARTICLE | Financial News

CureVac completes venture financing

September 24, 2012 7:00 AM UTC

CureVac GmbH, Tuebingen, Germany Business: Cancer, Infectious Date completed: 9/18/12 Type: Venture financing Raised: €80 million ($104.9 million) Investor: dievini Hopp BioTech ...